Live Cell Cytotoxicity Studies: Documentation of the Interactions of Antitumor Active Dirhodium Compounds with Nuclear DNA
- 22 July 2009
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 131 (32) , 11353-11360
Abstract
The promising antitumor activity of dirhodium complexes has been known for over 30 years. There remains, however, a general lack of understanding of their activity in cellulo. In this study, we report the DNA interactions and activity in living cells of six monosubstituted dirhodium(II,II) complexes of general formula [Rh2(μ-O2CCH3)2(η1-O2CCH3)(L)(CH3OH)]+, where L = bpy (2,2′-bipyridine) (1), phen (1,10-phenanthroline) (2), dpq (dipyrido[3,2-f:2′,3′-h]quinoxaline) (3), dppz (dipyrido[3,2-a:2′,3′-c]phenazine) (4), dppn (benzo[i]dipyrido[3,2-a:2′,3′-c]phenazine) (5), and dap (4,7-dihydrodibenzo[de,gh][1,10]phenanthroline) (6). DNA interactions were investigated by UV/visible spectroscopy, relative viscosity measurements, and electrophoretic mobility shift assay. These measurements indicate that compound 5 exhibits the strongest interaction with DNA. Compound 5 also causes the most damage to DNA after cellular internalization, as evaluated by the alkaline comet assay. Compound 5, however, is not the most effective at inhibiting cell viability of the human cancer cells HeLa and COLO-316. The greater hydrophobicity of 5 as compared to that of 4, which is the most effective compound in the series, hinders its ability to reach its cellular target(s). Data from modulation studies of glutathione using N-acetylcysteine and l-buthionine-sulfoximine indicate that changes in glutathione levels do not affect the activity of these particular dirhodium complexes. These results suggest that glutathione is not the only agent involved in the deactivation of these dirhodium complexes.Keywords
This publication has 54 references indexed in Scilit:
- Catalytic organometallic anticancer complexesProceedings of the National Academy of Sciences, 2008
- DNA damage induced by novel demethylcantharidin-integrated platinum anticancer complexesBiochemical and Biophysical Research Communications, 2007
- Binding of DNA Purine Sites to Dirhodium Compounds Probed by Mass SpectrometryInorganic Chemistry, 2004
- Stabilization of Duplex DNA Structure and Suppression of Transcription in Vitro by Bis(quinone diimine) Complexes of Rhodium(III) and Ruthenium(II)Inorganic Chemistry, 2003
- Potential for selective modulation of glutathione in cancer chemotherapyChemico-Biological Interactions, 1998
- Properties of rhodium (II) complexes having cytostatic activityJournal of Inorganic Biochemistry, 1996
- Synthesis, photophysical properties and DNA binding studies of novel luminescent rhenium(I) complexes. X-Ray crystal structure of [Re(dppn)(CO)3(py)](OTf)Journal of the Chemical Society, Chemical Communications, 1995
- Reaction of 2,2'-bipyridine (bpy) with dirhodium carboxylates: mono-bpy products with variable chelate binding modes and insights into the reaction mechanismInorganic Chemistry, 1993
- Conformation of platinum-trinucleotide adduct Pt(dien)[d(ApGpA)-N7(2)] in the solid state and in aqueous solution, as determined with single-crystal x-ray diffraction and high-resolution NMR spectroscopy in solutionJournal of the American Chemical Society, 1992
- The interaction of closed circular DNA with intercalative dyesJournal of Molecular Biology, 1968